Associate Professor
University of Toronto
Toronto, Ontario, Canada
Dr. Carolyn Cummins is an Associate Professor and Graduate Director of Pharmaceutical Sciences in the Leslie Dan Faculty of Pharmacy, and Co-Director of the Next Generation Precision Medicine Initiative (PRiME), an institutional strategic initiative, at the University of Toronto. She completed her undergraduate degree in chemistry at McGill University and her Ph.D. in pharmaceutical chemistry at UCSF. She gained molecular biology and in vivo pharmacology experience in nuclear hormone receptors during her postdoctoral training at UT Southwestern Medical Center in Dallas. Her research program is interdisciplinary and focuses on the study of nuclear hormone receptors in metabolic diseases, focusing on drug target validation and early drug discovery. With expertise in pharmacokinetics, analytical chemistry, cell and molecular biology, and small animal physiology, her group is exploring the use of LXRbeta antagonists as a therapy to prevent metabolic complications of glucocorticoid treatment. Dr. Cummins has co-authored over 80 research publications and 3 patents and holds funding from CIHR, IDRC, HSFC and NSERC. She is passionate about promoting translation of academic discoveries to practice and is helping to grow PRiME as a community hub and knowledge broker that promotes innovations in early drug discovery and diagnostics at the University of Toronto.
Disclosure information not submitted.
Monday, October 17, 2022
8:30 AM – 9:00 AM ET